Orally-active ice inhibitors for the treatment of inflammatory and autoimmune diseases.

被引：0
|
作者：
Randle, JCR [1 ]
机构：
[1] Vertex Pharmaceut Inc, Cambridge, MA 02319 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2004年 / 228卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
200-MEDI
引用
收藏
页码：U944 / U944
页数：1
相关论文
共 50 条
  • [31] Venous thromboembolism treatment duration in autoimmune diseases. Research trends
    Ruiz-Sada, Pablo
    Palacios-Garcia, Lara
    Sada-Sainz, Julia
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 95 : 100 - 101
  • [32] Complement and complement inhibitors: their role in autoimmune and inflammatory diseases
    Sheerin, NS
    Sacks, SH
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1998, 7 (03): : 305 - 310
  • [33] Toxicities of single agent and combination immune checkpoint inhibitors in patients with autoimmune diseases.
    Cytryn, Samuel
    Efuni, Elizaveta
    Sandigursky, Sabina
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] 1,2-DIARYLCYCLOPENTENES AS SELECTIVE CYCLOOXYGENASE-2 INHIBITORS AND ORALLY-ACTIVE ANTIINFLAMMATORY AGENTS
    LI, JJ
    ANDERSON, GD
    BURTON, EG
    COGBURN, JN
    COLLINS, JT
    GARLAND, DJ
    GREGORY, SA
    HUANG, HC
    ISAKSON, PC
    KOBOLDT, CM
    LOGUSCH, EW
    NORTON, MB
    PERKINS, WE
    REINHARD, EJ
    SEIBERT, K
    VEENHUIZEN, AW
    ZHANG, Y
    REITZ, DB
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (22) : 4570 - 4578
  • [35] Expression of cysteine proteinases and metalloproteinases and their specific inhibitors in inflammatory joint diseases.
    Redlich, A
    Haupl, T
    Sparmann, M
    Zacher, J
    Ungethum, U
    Keysser, G
    Burmester, GR
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1312 - 1312
  • [36] Exploring the Clinical Potential of Siglec-1 Immunoassay in Autoimmune and Inflammatory Diseases.
    Iype, J.
    Fux, M.
    Hogervorst, J.
    Wirthmuller, U.
    Horn, M.
    Steiner, U.
    SWISS MEDICAL WEEKLY, 2023, 153 : 22S - 22S
  • [37] Development of TLR inhibitors for the treatment of autoimmune diseases
    Barrat, Franck J.
    Coffman, Robert L.
    IMMUNOLOGICAL REVIEWS, 2008, 223 : 271 - 283
  • [38] Kinase inhibitors for the treatment of inflammatory and autoimmune disorders
    Shripad S. Bhagwat
    Purinergic Signalling, 2009, 5
  • [39] Kinase inhibitors for the treatment of inflammatory and autoimmune disorders
    Bhagwat, Shripad S.
    PURINERGIC SIGNALLING, 2009, 5 (01) : 107 - 115
  • [40] Orally active Chelators for the treatment of iron overload diseases
    Chin, AP
    Bernhardt, PV
    Richardson, DR
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2003, 96 (01) : 118 - 118
12345